A recent study in India evaluated the molecular biomarkers of brain tumours in Indian patients [36] and reported a high prevalence of isocitrate dehydrogenase 1 (IDH1) mutation in astrocytoma and glioblastoma in these patients [37]. Here, IDH1 is linked to glioblastoma.